As of 30 Sep 2025, 2 institutional investors reported holding 28,963 shares of AstraZeneca PLC - Common Stock - Foreign.
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2025 Q3 | 28,963 | $4,357,628 | +$480,006 | $150.46 | 2 |
| 2025 Q2 | 25,774 | $3,577,918 | +$2,125,489 | $138.80 | 2 |
| 2025 Q1 | 10,473 | $1,521,339 | -$954,151 | $145.32 | 2 |
| 2024 Q4 | 17,744 | $2,326,248 | +$718,295 | $131.10 | 3 |
| 2024 Q3 | 12,265 | $1,906,384 | +$5,112 | $155.18 | 2 |
| 2024 Q2 | 12,232 | $1,910,542 | -$343,623 | $156.19 | 2 |
| 2024 Q1 | 14,432 | $1,946,726 | -$103,599 | $134.84 | 2 |
| 2023 Q4 | 15,200 | $2,053,957 | -$30,404 | $135.13 | 1 |
| 2023 Q3 | 15,425 | $2,090,171 | +$2,090,171 | $135.51 | 1 |
| 2023 Q1 | 0 | $0 | -$1,066,846 | $150.46 | 0 |
| 2022 Q4 | 7,906 | $1,066,846 | +$135,751 | $134.94 | 1 |
| 2022 Q3 | 6,900 | $765,933 | $0 | $111.00 | 1 |
| 2022 Q2 | 6,900 | $905,008 | -$498,410 | $131.16 | 1 |
| 2022 Q1 | 10,700 | $1,427,412 | $0 | $133.40 | 1 |
| 2021 Q4 | 10,700 | $1,257,669 | $0 | $117.54 | 1 |
| 2021 Q3 | 10,700 | $1,292,402 | +$1,292,402 | $120.79 | 1 |
| 2015 Q3 | 0 | $0 | -$66,894,052 | $150.46 | 0 |
| 2015 Q2 | 1,058,338 | $66,894,000 | -$81,504,218 | $63.21 | 1 |
| 2015 Q1 | 2,347,825 | $161,249,000 | +$118,346,149 | $68.68 | 1 |
| 2014 Q4 | 624,677 | $44,372,000 | +$44,371,994 | $71.03 | 1 |
| 2014 Q2 | 8,850 | $657 | $0 | $0.07 | 1 |
| 2014 Q1 | 0 | $0 | -$480,000 | $150.46 | 0 |